74: 2 Fast 2 Feverish: Late ID Complications of CAR-T therapy

1

Introduction

00:00 • 1min

2

The Late Complications of CAR T

01:20 • 4min

3

Cloit Infections After CD19 CAR-T

05:19 • 3min

4

The Effects of CAR T on Respiratory Viral Infections

08:14 • 4min

5

Ribavirin and RSV: A Comparison

12:10 • 5min

6

The Importance of Vaccinations After CAR T

17:13 • 6min

7

BCMA Carty and the Infectious Risk Framework

22:58 • 2min

8

CD19 Carty and Hypogammaglobininemia

24:42 • 3min

9

The Benefits of IV IgG Replacement for BCMA Carty

27:54 • 3min

10

The Risk of Infection in the BCMA Group

30:43 • 3min

11

CMV and End Organ Disease

33:23 • 3min

12

CMV and HHV6 Reactivation in CAR T Cells

36:11 • 4min

13

The Risk of Invasive Fungal Infections in Patients With ALL

40:01 • 4min

14

The Role of Mold-Active Prophylaxis in High-Risk Patients

44:21 • 2min